Concha Amador

1.0k total citations
23 papers, 435 citations indexed

About

Concha Amador is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Concha Amador has authored 23 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Concha Amador's work include HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). Concha Amador is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). Concha Amador collaborates with scholars based in Spain, United States and Mexico. Concha Amador's co-authors include Javier Ena, Francisco Pasquau, Francisco J. Arjona, Victoria Ortiz de la Tabla, Calvin M. Kunin, Vicente Abril, J Lacruz, C Redondo, Juan Flores and Félix Gutiérrez and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Urology and AIDS.

In The Last Decade

Concha Amador

22 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Concha Amador Spain 10 290 116 92 79 71 23 435
C. Flateau France 9 102 0.4× 126 1.1× 43 0.5× 127 1.6× 17 0.2× 30 355
Silvia Boni Italy 10 167 0.6× 117 1.0× 207 2.3× 13 0.2× 38 0.5× 30 481
Elisabetta Grilli Italy 13 177 0.6× 99 0.9× 79 0.9× 20 0.3× 12 0.2× 25 388
M S Simberkoff United States 8 282 1.0× 209 1.8× 60 0.7× 35 0.4× 12 0.2× 8 470
Rishma Amarsy France 10 154 0.5× 139 1.2× 98 1.1× 16 0.2× 19 0.3× 17 354
Abdurahaman Seid Ethiopia 12 129 0.4× 132 1.1× 41 0.4× 12 0.2× 42 0.6× 27 385
Spyridon Karageorgos Greece 12 93 0.3× 154 1.3× 73 0.8× 66 0.8× 14 0.2× 30 427
D. Soko Malawi 6 196 0.7× 119 1.0× 21 0.2× 80 1.0× 11 0.2× 8 341
Paola Tatarelli Italy 11 119 0.4× 145 1.3× 38 0.4× 26 0.3× 24 0.3× 23 303
Dariusz Kawecki Poland 13 196 0.7× 108 0.9× 66 0.7× 109 1.4× 49 0.7× 42 478

Countries citing papers authored by Concha Amador

Since Specialization
Citations

This map shows the geographic impact of Concha Amador's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concha Amador with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concha Amador more than expected).

Fields of papers citing papers by Concha Amador

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concha Amador. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concha Amador. The network helps show where Concha Amador may publish in the future.

Co-authorship network of co-authors of Concha Amador

This figure shows the co-authorship network connecting the top 25 collaborators of Concha Amador. A scholar is included among the top collaborators of Concha Amador based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concha Amador. Concha Amador is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuster‐RuizdeApodaca, María José, Marı́a José Galindo, & Concha Amador. (2024). Patients’ and specialists’ perspectives on health care quality and on people living with HIV health-related quality of life in Spain: a cross-sectional survey. AIDS Care. 36(11). 1606–1616.
2.
Navarro, Jordi, Adrián Curran, Berta Raventós, et al.. (2023). Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.. European Journal of Internal Medicine. 110. 54–61. 6 indexed citations
3.
Ramos, José Manuel, Diego Torrús, Adelina Gimeno, et al.. (2023). Cytokine profile levels and their relationship with parasitemia and cardiomyopathy in people with Chagas disease in Spain. A prospective observational study. Parasitology Research. 123(1). 66–66. 1 indexed citations
4.
Deltoro, Miguel García, Juan Flores, Marta Montero, et al.. (2017). Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients. AIDS. 32(3). 337–346. 4 indexed citations
5.
Riera, Melchor, Herminia Esteban, Rosario Palacios, et al.. (2015). Validación y cumplimentación de los indicadores de calidad GESIDA en pacientes con infección por el VIH. Enfermedades Infecciosas y Microbiología Clínica. 34(6). 346–352. 5 indexed citations
6.
Portilla, Joaquín, Piedad Arazo, Laura Pérez‐Martínez, et al.. (2014). Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV‐patients. The BITER Study. Journal of the International AIDS Society. 17(4S3). 19803–19803. 6 indexed citations
7.
Ortega, Enrique, Juan Flores, Mar Masiá, et al.. (2014). Telaprevir or boceprevir in HIV/HCV‐1 co‐infected patients in a real‐life setting. Interim analysis (24 weeks). COINFECOVA‐SEICV study. Journal of the International AIDS Society. 17(4S3). 19634–19634. 1 indexed citations
8.
Merchante, Nicolás, Esperanza Merino, José López-Aldeguer, et al.. (2012). Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain. Clinical Infectious Diseases. 56(1). 143–150. 51 indexed citations
9.
Ena, Javier, et al.. (2012). Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations. HIV/AIDS - Research and Palliative Care. 4. 169–169. 9 indexed citations
10.
Ena, Javier, et al.. (2010). Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients. European Journal of Internal Medicine. 22(1). 66–72. 2 indexed citations
11.
Ena, Javier, et al.. (2006). Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology. 68(6). 1169–1174. 80 indexed citations
12.
Ena, Javier, et al.. (2006). Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis. Enfermedades Infecciosas y Microbiología Clínica. 24(4). 232–237. 6 indexed citations
13.
Amador, Concha, et al.. (2005). Interrupción del tratamiento antirretroviral en pacientes con infección crónica por el virus de la inmunodeficiencia humana. Medicina Clínica. 125(2). 41–45. 1 indexed citations
14.
Pasquau, Francisco, Javier Ena, Concha Amador, et al.. (2005). Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. European Journal of Clinical Microbiology & Infectious Diseases. 24(6). 411–418. 68 indexed citations
15.
16.
Ena, Javier, et al.. (2003). Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients. International Journal of STD & AIDS. 14(11). 776–781. 36 indexed citations
17.
Amador, Concha, et al.. (2001). Factores de riesgo asociados a la aparición de infecciones durante el primer año de tratamiento antirretroviral de alta eficacia. Medicina Clínica. 116(2). 41–46. 7 indexed citations
18.
Amador, Concha, et al.. (2000). [Therapeutic data on chloroquine diphosphate in rheumatoid arthritis].. PubMed. 14(1-6). 1–3. 1 indexed citations
19.
20.
Betlloch, Isabel, et al.. (1991). Erythema Annular Centrifugum in Q Fever. International Journal of Dermatology. 30(7). 502–502. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Flateau Breakdown of academic impact, for papers by Silvia Boni Breakdown of academic impact, for papers by Elisabetta Grilli Breakdown of academic impact, for papers by M S Simberkoff Breakdown of academic impact, for papers by Rishma Amarsy Breakdown of academic impact, for papers by Abdurahaman Seid Breakdown of academic impact, for papers by Spyridon Karageorgos Breakdown of academic impact, for papers by D. Soko Breakdown of academic impact, for papers by Paola Tatarelli Breakdown of academic impact, for papers by Dariusz Kawecki
Rankless by CCL
2026